1. Spinal Muscular Atrophy: Genetics And Recent Advancement In Gene Therapy.
- Author
-
Yanyu Dong
- Subjects
TREATMENT of spinal muscular atrophy ,GENE therapy ,NEURODEGENERATION ,MUSCLE weakness ,ETIOLOGY of diseases - Abstract
Spinal muscular atrophy (SMA) is a devastating genetic disease occurring ~1 in every 10,000 live births globally with varied mortality rates based on different severity of the disease. It is a recessive neurodegenerative disease (ND) with various severity due to different ages of onset. There is also a wide range of symptoms experienced by the patients, from muscle weaknesses to abnormal breathing patterns. However, all symptoms share one specific genetic etiology - survival motor neuron (SMN) protein deficiency due to mutations or deletions of the SMN1 gene. In this review, the in-depth structural concept regarding aspects of SMA, including its cause at a molecular level, is summarized; the recent novel establishment of two existing gene therapies, Spinraza and Zolgensma, is discussed, regarding mechanism and limitations. We further propose possible goals to pursue novel developments of SMA therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF